In addition to the physical exam and functional assessment, which of the following is used to assess response to treatment for rheumatoid arthritis?

Choice A reason: White blood cell measurement is not a specific or sensitive indicator for rheumatoid arthritis activity or response to treatment. White blood cells can be elevated in any infection, inflammatory state, or due to certain medications, but they do not directly reflect joint inflammation or autoimmune activity in rheumatoid arthritis. WBC levels are useful primarily for detecting infection or bone marrow suppression due to drug therapy rather than monitoring disease progression. Choice B reason: The erythrocyte sedimentation rate (ESR) is a reliable and widely used indicator of inflammation and is commonly utilized to assess response to treatment in rheumatoid arthritis. ESR measures the rate at which red blood cells settle at the bottom of a test tube over one hour. An increased rate reflects elevated levels of acute-phase proteins such as fibrinogen, which correlate with systemic inflammation. When treatment is effective and inflammation subsides, the ESR value decreases, making it a sensitive marker for monitoring disease activity over time. Choice C reason: Hemoglobin measurement primarily assesses for anemia, which may be secondary to chronic inflammation or bone marrow suppression from medications. Although anemia can occur in rheumatoid arthritis (known as anemia of chronic disease), hemoglobin levels are not used to gauge response to therapy or inflammation levels. Choice D reason: Measurement of absolute neutrophils helps detect neutropenia or infection, particularly in patients on immunosuppressive therapy, but it does not measure inflammatory activity or disease response. It is mainly a safety monitoring parameter, not a treatment response marker.